Visual inspection as a cervical cancer screening method in a primary health care setting in Africa

International Journal of Cancer

Volumn 119, Issue 6, 2006, Pages 1389-1395

  Sangwa Lugoma, Ghislain ^a,b,c   Mahmud, Salaheddin ^c   Nasr, Samih H ^c   Liaras, Jean ^d   Kayembe, Patrick K ^e   Tozin, Rahma R ^a   Drouin, Pierre ^f   Lorincz, Attila ^g   Ferenczy, Alex ^c,h   Franco, Eduardo L ^c  

^a UNIVERSITY OF KINSHASA   (Congo)

^b UNIVERSITY OF ALBERTA   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d Groupement de Recherche Cytologique   (France)

^e Ecole de Santé Publique de Kinshasa   (Congo)

^f CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^g Digene Corporation   (United States)

^h MCGILL UNIVERSITY   (Canada)

Author keywords

Cervical cancer; Cervical intraepithelial neoplasia; Pap cytology; Screening; Visual inspection

Indexed keywords

ACETIC ACID; LUGOL;

ADULT; AFRICA; ARTICLE; CANCER GRADING; CANCER SCREENING; COLPOSCOPY; CONGO; CONTROLLED STUDY; COST; FEASIBILITY STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NURSE; PAPANICOLAOU TEST; PHYSICIAN; PREVALENCE; PRIMARY HEALTH CARE; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; UTERUS BIOPSY;

ACETIC ACID; ADULT; BIOPSY; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; CROSS-SECTIONAL STUDIES; DEMOCRATIC REPUBLIC OF THE CONGO; FEASIBILITY STUDIES; FEMALE; HUMANS; IODIDES; MASS SCREENING; MIDDLE AGED; PHYSICAL EXAMINATION; PRIMARY HEALTH CARE; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 33747482001     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.21972     Document Type: Article

References (23)

1. Parkin DM, Bray FI, Devassa SS. Cancer burden in the year 2000: the global picture. Eur J Cancer 2001;37:S4-66.
2. Franco EL, Duarte-Franco E, Ferenczy A. Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. CMAJ 2001;164:1017-25.
3. Gaffikin L, Blumenthal PD, Davis C, Brechin SJG, eds. Alternatives for cervical cancer screening and treatment in low-resource settings: workshop proceedings, May 21-22, 1997, Baltimore: JHPIEGO Corporation, 1997.
4. Sankaranarayanan R, Wesley R, Thara S, Dhakad N, Chandralekha B, Sebastian P, Chithrathara K, Parkin DM, Nair MK. Test characteristics of visual inspection with 4% acetic acid (VIA) and Lugol's iodine (VILI) in cervical cancer screening in Kerala, India. Int J Cancer 2003;106:404-8.
5. Miller AB, Nazeer S, Fonn S, Brandup-Lukanow A, Rehman R, Cronje H, Sankaranarayanan R, Koroltchouk V, Syrjänen K, Singer A, Onsrud M. Report on consensus conference on cervical cancer screening and management. Int J Cancer 2000;86: 440-4.
6. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright Jr. T, Young N. The 2001 Bethesda system: terminology for reporting results of cervical cytology. JAMA 2002;287:2114-9.
7. Reid R, Scalzi P. Genital warts and cervical cancer: VII, an improved colposcopic index for differentiating benign papillomaviral infections from high-grade cervical intraepithelial neoplasia. Am J Obstet Gynecol 1985;153:611-8.
8. Ferenczy A, Ritter J, Cestero RM. Practical color atlas of cervical colposcopy. Anjou, Qc, Canada: BioVision Inc., 2000.
9. Nazeer S. Aided visual inspection of the cervix "acetic acid test" picture atlas, Aldo Campana, eds, 2003. http//www.gfmr.ch/Books/ Cervical_inspection_atlas.htm (August 13, 2003).
10. Franco EL. Statistical issues in human papillomavirus testing and screening. Clin Lab Med 2000;20:345-67.
11. Choi BC. Sensitivity and specificity of a single diagnostic test in the presence of work-up bias. J Clin Epidemiol 1992;45:581-6.
12. Ratnam S, Franco EL, Ferenczy A. Human Papillomavirus testing for primary cervical cancer precursors. Cancer Epidemiol Biomark Prev 2000;9:945-51.
13. Reichenheim M, Ponce de Leon L. Estimation of sensitivity and specificity arising from validity studies with incomplete designs. The Stata Journal 2002;2:267-79.
14. Franco EL, Ferenczy A. Assessing gains in diagnostic utility when human papillomavirus testing is used as an adjunct to papanicolaou smear in the triage of women with cervical cytologic abnormalities. Am J Obstet Gynecol 1999;181:382-6.
15. Belinson JL, Pretorius RG, Zhang WH, Wu LY, Qiao YL, Elson P. Cervical cancer screening by simple visual inspection after acetic acid. Obstet Gynecol 2001;98:441-4.
16. University of Zimbabwe/JHPIEGO Cervical Cancer Project. Visual inspection with acetic acid for cervical cancer screening: test qualities in a primary-care setting. Lancet 1999;353:869-73.
17. Sankaranarayanan R, Basu P, Wesley R, Mahe C, Keita N, Gombe Mbalawa C, Sharma R, Dolo A, Shastri S, Nacoulma M, Nayama M, Somanathan T, et al. Accuracy of visual screening for cervical neoplasia: results from an IARC multicentre study in India and Africa. Int J Cancer 2004;110:907-13.
18. Denny L, Kühn L, Pollack A, Wright TC, Jr. Direct visual inspection for cervical cancer screening: an analysis of factors influencing test performance. Cancer 2002;94:1699-707.
19. Bhatla N, Mukhopadhyay A, Joshi S, Kumar A, Kriplani A, Pandey RM, Verma K. Visual inspection for cervical cancer screening; evaluation by doctor versus paramedical worker. Indian J Cancer 2004;41:32-6.
20. Nanda K, McCrory DC, Myers ER, Bastian LA, Hasselblad V, Hickey JD, Matchar DB. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med 2000;132:810-9.
21. Fahey MT, Irwig L, Macaskill P. Meta-analysis of Pap test accuracy. Am J Epidemiol 1995;141:680-9.
22. Denny L, Kühn L, De Souza M, Pollack AE, Dupree W, Wright TC, Jr. Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial. JAMA 2005;294:2173-81.
23. Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, Gordillo-Tobar A, Levin C, Mahe C, Wright TC, Alliance for Cervical Cancer Prevention Cost Working Group. Cost-effectiveness of cervical-cancer screening in five developing countries. N Engl J Med 2005;353:2158-68.